These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Hepatitis B virus-like particles access major histocompatibility class I and II antigen presentation pathways in primary dendritic cells. Moffat JM; Cheong WS; Villadangos JA; Mintern JD; Netter HJ Vaccine; 2013 Apr; 31(18):2310-6. PubMed ID: 23473776 [TBL] [Abstract][Full Text] [Related]
43. Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance. Bonifaz L; Bonnyay D; Mahnke K; Rivera M; Nussenzweig MC; Steinman RM J Exp Med; 2002 Dec; 196(12):1627-38. PubMed ID: 12486105 [TBL] [Abstract][Full Text] [Related]
44. Microfluidic Squeezing Enables MHC Class I Antigen Presentation by Diverse Immune Cells to Elicit CD8 Booty MG; Hlavaty KA; Stockmann A; Ozay EI; Smith C; Tian L; How E; Subramanya D; Venkitaraman A; Yee C; Pryor O; Volk K; Blagovic K; Vicente-Suarez I; Yarar D; Myint M; Merino A; Chow J; Abdeljawad T; An H; Liu S; Mao S; Heimann M; Talarico L; Jacques MK; Chong E; Pomerance L; Gonzalez JT; von Andrian UH; Jensen KF; Langer R; Knoetgen H; Trumpfheller C; Umaña P; Bernstein H; Sharei A; Loughhead SM J Immunol; 2022 Feb; 208(4):929-940. PubMed ID: 35091434 [TBL] [Abstract][Full Text] [Related]
45. The show and tell of cross-presentation. Blander JM; Yee Mon KJ; Jha A; Roycroft D Adv Immunol; 2023; 159():33-114. PubMed ID: 37996207 [TBL] [Abstract][Full Text] [Related]
46. Non-equivalent antigen presenting capabilities of dendritic cells and macrophages in generating brain-infiltrating CD8 Malo CS; Huggins MA; Goddery EN; Tolcher HMA; Renner DN; Jin F; Hansen MJ; Pease LR; Pavelko KD; Johnson AJ Nat Commun; 2018 Feb; 9(1):633. PubMed ID: 29434238 [TBL] [Abstract][Full Text] [Related]
47. Differential use of autophagy by primary dendritic cells specialized in cross-presentation. Mintern JD; Macri C; Chin WJ; Panozza SE; Segura E; Patterson NL; Zeller P; Bourges D; Bedoui S; McMillan PJ; Idris A; Nowell CJ; Brown A; Radford KJ; Johnston AP; Villadangos JA Autophagy; 2015; 11(6):906-17. PubMed ID: 25950899 [TBL] [Abstract][Full Text] [Related]
48. Cross-Presentation Assay for Human Dendritic Cells. Segura E Methods Mol Biol; 2016; 1423():189-98. PubMed ID: 27142018 [TBL] [Abstract][Full Text] [Related]
49. Dendritic cells cross-dressed with peptide MHC class I complexes prime CD8+ T cells. Dolan BP; Gibbs KD; Ostrand-Rosenberg S J Immunol; 2006 Nov; 177(9):6018-24. PubMed ID: 17056526 [TBL] [Abstract][Full Text] [Related]
50. Bioinspired vaccines to enhance MHC class-I antigen cross-presentation. Baljon JJ; Wilson JT Curr Opin Immunol; 2022 Aug; 77():102215. PubMed ID: 35667222 [TBL] [Abstract][Full Text] [Related]
51. Viral sequestration of antigen subverts cross presentation to CD8(+) T cells. Tewalt EF; Grant JM; Granger EL; Palmer DC; Heuss ND; Gregerson DS; Restifo NP; Norbury CC PLoS Pathog; 2009 May; 5(5):e1000457. PubMed ID: 19478869 [TBL] [Abstract][Full Text] [Related]
52. Antigen storage compartments in mature dendritic cells facilitate prolonged cytotoxic T lymphocyte cross-priming capacity. van Montfoort N; Camps MG; Khan S; Filippov DV; Weterings JJ; Griffith JM; Geuze HJ; van Hall T; Verbeek JS; Melief CJ; Ossendorp F Proc Natl Acad Sci U S A; 2009 Apr; 106(16):6730-5. PubMed ID: 19346487 [TBL] [Abstract][Full Text] [Related]
53. Perforin-2 is a pore-forming effector of endocytic escape in cross-presenting dendritic cells. Rodríguez-Silvestre P; Laub M; Krawczyk PA; Davies AK; Schessner JP; Parveen R; Tuck BJ; McEwan WA; Borner GHH; Kozik P Science; 2023 Jun; 380(6651):1258-1265. PubMed ID: 37347855 [TBL] [Abstract][Full Text] [Related]
54. The comings and goings of MHC class I molecules herald a new dawn in cross-presentation. Blander JM Immunol Rev; 2016 Jul; 272(1):65-79. PubMed ID: 27319343 [TBL] [Abstract][Full Text] [Related]
55. Cross-dressing: an alternative mechanism for antigen presentation. Campana S; De Pasquale C; Carrega P; Ferlazzo G; Bonaccorsi I Immunol Lett; 2015 Dec; 168(2):349-54. PubMed ID: 26551033 [TBL] [Abstract][Full Text] [Related]
56. Dendritic cell-mediated cross presentation of tumor-derived peptides is biased against plasma membrane proteins. Fessenden TB; Stopfer LE; Chatterjee F; Zulueta J; Mesfin J; Cordero Dumit T; Reijers I; Hoefsmit EP; Blank C; White F; Spranger S J Immunother Cancer; 2022 Jul; 10(7):. PubMed ID: 35820727 [TBL] [Abstract][Full Text] [Related]
57. Antigen cross-presentation by dendritic cell subsets: one general or all sergeants? Nierkens S; Tel J; Janssen E; Adema GJ Trends Immunol; 2013 Aug; 34(8):361-70. PubMed ID: 23540650 [TBL] [Abstract][Full Text] [Related]
58. Dendritic cells use endocytic pathway for cross-priming class Ib MHC-restricted CD8alphaalpha+TCRalphabeta+ T cells with regulatory properties. Smith TR; Tang X; Maricic I; Garcia Z; Fanchiang S; Kumar V J Immunol; 2009 Jun; 182(11):6959-68. PubMed ID: 19454693 [TBL] [Abstract][Full Text] [Related]
59. IRAP identifies an endosomal compartment required for MHC class I cross-presentation. Saveanu L; Carroll O; Weimershaus M; Guermonprez P; Firat E; Lindo V; Greer F; Davoust J; Kratzer R; Keller SR; Niedermann G; van Endert P Science; 2009 Jul; 325(5937):213-7. PubMed ID: 19498108 [TBL] [Abstract][Full Text] [Related]